# HexaVax-MAPS v3 Case Report
## VAERS ID: 983362 | MYOCARDITIS | Group: G2 (Confounded — Viral Etiology)

---

## Phase 1: Data Preprocessing & Diagnosis Filtering

### Stage 1: ICSR Extractor (LLM) — Data Intake

| Field | Value |
|-------|-------|
| **Patient** | 25.0yo F, CA |
| **Vaccine** | COVID19 (MODERNA) |
| **Dose** | #1 (2021-01-08) |
| **Onset** | 2021-01-13 (5.0d post-vax) |
| **Primary Dx** | myocarditis |
| **Symptoms** | myalgia, fever, shortness of breath, chest pain, pyrexia, troponin increased |

**Narrative:** 25-year-old female developed myalgia, fever, shortness of breath, and chest pain 7 days after Moderna COVID-19 vaccination. Patient was hospitalized and diagnosed with myocarditis with elevated cardiac biomarkers.

| Lab/Test | Value | Elevated? |
|----------|-------|-----------|
| Troponin | 3.7 | True |
| ECG | ST segment depression in III, aVF, V4, V5 | |
| Other Labs | CKMB: >27 | |

**Outcomes:** Hospitalized=True, Days=8, Life-threatening=True, Recovered=Y
**Data Quality:** 7/10 | Missing: echo_findings, cardiac_mri

---

### Stage 2: Clinical Validator (Rule-based) — WHO Step 0: Valid Diagnosis

| Field | Value |
|-------|-------|
| **Brighton Level** | **Level 2** |
| **Justification** | Elevated troponin + abnormal ECG + compatible symptoms |
| **Engine** | DETERMINISTIC (Rule-based) |
| **Early Exit** | False |

| Criterion | Met? |
|-----------|------|
| Histopathology | False |
| Cardiac MRI+ | False |
| **Troponin Elevated** | **True** |
| **ECG Abnormal** | **True** |
| Echo Abnormal | False |
| **Compatible Symptoms** | **True** |

> **Gate Decision: PASS** — Brighton L2, proceed to Phase 2.

---

## Phase 2: Mechanistic Investigation

### Stage 3: DDx Specialist (LLM + Narrative) — WHO Step 1: Other Causes?

| Alternative Etiology | NCI | Status | Key Evidence |
|---------------------|-----|--------|--------------|
| Viral myocarditis (COVID-19 infection itself) | ██░░░░░░░░ **0.2** | NOT_EVALUATED | No mention of COVID-19 testing or recent COVID infection in narrative. Timeline ... |
| Viral myocarditis (other: influenza, enterovi | █████░░░░░ **0.5** | SUSPECTED | Reporter explicitly states 'Difficult to elucidate whether the myocarditis was s... |
| Autoimmune/inflammatory (SLE, sarcoidosis, gi | █░░░░░░░░░ **0.1** | NOT_EVALUATED | No inflammatory markers reported, no mention of autoimmune history or systemic s... |
| Drug-induced cardiotoxicity | ░░░░░░░░░░ **0.0** | EXCLUDED | Only medication listed is Tylenol, which is not cardiotoxic. No other drugs ment... |
| Ischemic heart disease (CAD, MI) | ███░░░░░░░ **0.3** | SUSPECTED | ECG shows ST depression in multiple leads (III, aVF, V4, V5), but patient is you... |
| Other infections (bacterial endocarditis, Lym | █░░░░░░░░░ **0.1** | NOT_EVALUATED | No mention of blood cultures, vegetation on echo, or systemic infection signs. N... |
| Pre-existing cardiac condition | ░░░░░░░░░░ **0.0** | EXCLUDED | No prior cardiac conditions listed in medical history. Young patient with no men... |
| Substance use (alcohol, cocaine, amphetamines | █░░░░░░░░░ **0.1** | NOT_EVALUATED | No substance use mentioned in narrative or history. Not evaluated with toxicolog... |

**Max NCI:** **0.5** | **Dominant Alternative:** Viral myocarditis (other viral etiologies)
**WHO Step 1:** **POSSIBLE_OTHER_CAUSE**

**Clinical Reasoning:** The reporter explicitly acknowledges diagnostic uncertainty, stating difficulty distinguishing between vaccine-induced myocarditis versus other viral etiologies. The presence of fever and myalgia could represent viral prodrome, and the absence of viral testing prevents exclusion of concurrent viral infection. However, the 5-day onset after vaccination and clinical presentation are also consistent with vaccine-associated myocarditis, creating genuine diagnostic ambiguity.

**Information Gaps:**
- Viral testing (PCR, serology) not performed
- Inflammatory markers (CRP, ESR) not reported
- Echocardiogram findings not provided
- Cardiac MRI not performed
- Blood cultures not mentioned
- Toxicology screening not performed

---

### Stage 4: Temporal & Known AE Auditor (Rule-based) — WHO Step 2

#### Known AE Assessment
| Field | Value |
|-------|-------|
| **Is Known AE** | **True** |
| **Evidence Level** | ESTABLISHED |
| **Source** | NAM 2024 Evidence Review |

#### Temporal Assessment
| Field | Value |
|-------|-------|
| **Days to Onset** | **5.0d** |
| **Temporal Zone** | **STRONG_CAUSAL** |
| **NAM 2024** | WITHIN_WINDOW |

**WHO Step 2 Met:** **True** | High Risk: False

---

## Phase 3: Judgment & Reporting

### Stage 5: Causality Integrator (LLM) — WHO Step 3 & 4

# WHO Category: **B2** — Indeterminate (conflicting factors)
**Confidence:** HIGH

### Decision Tree Trace
| Question | Answer |
|----------|--------|
| Q1: Valid diagnosis? | True (Brighton L2) |
| Q2: Definite other cause? | False |
| Q3: Known AE? | **True** |
| Q4: Temporal met? | **True** (STRONG_CAUSAL) |
| Q5: Conflicting alternatives? | **True** (NCI=0.5) |

**Key Factors:**
1. Established vaccine-AE pair (mRNA → myocarditis)
2. Excellent temporal relationship (day 5, within peak window)
3. Competing viral etiology with clinical support (fever, myalgia)
4. Reporter explicitly acknowledges diagnostic uncertainty
5. No viral testing performed to exclude alternative

**Reasoning:** This case represents a classic B2 scenario with conflicting trends of evidence. The vaccine-myocarditis association is well-established (NAM 2024) and the temporal relationship is excellent (day 5, STRONG_CAUSAL zone). However, there is meaningful competing evidence for viral myocarditis: fever and myalgia suggest possible viral prodrome (NCI 0.5), and the reporter explicitly states 'Difficult to elucidate whether the myocarditis was secondary to Moderna vaccination or other viral etiologies.' The absence of viral testing prevents definitive exclusion of this alternative. Evidence trends BOTH toward vaccine causation (known AE, temporal, clinical presentation) AND toward coincidental viral myocarditis (prodromal symptoms, clinical uncertainty). Cannot clearly favour one explanation over the other.

---

### Stage 6: Guidance Advisor (LLM) — Reporting

**Risk Signal:** **HIGH** | **Escalation:** True

### Investigative Gaps
| Priority | Gap | Action |
|----------|-----|--------|
| **CRITICAL** | Viral testing (PCR, serology) not performed to exclude concurrent vira | Request viral panel results from treating facility - PCR for common ca... |
| **HIGH** | Echocardiogram findings not provided despite hospitalization | Obtain complete echocardiogram report from hospital records - assess w... |
| **HIGH** | Inflammatory markers (CRP, ESR) not reported | Request complete laboratory panel from hospitalization including CRP, ... |
| **MEDIUM** | Cardiac MRI not performed for definitive myocarditis diagnosis | Inquire if cardiac MRI was considered or performed during hospitalizat... |

### Officer Summary
> This 25-year-old woman developed myocarditis 5 days after Moderna vaccination, which fits the known pattern for vaccine-associated myocarditis. However, she also had fever and muscle aches that could indicate a viral infection instead. The key missing piece is viral testing - getting those results could determine whether this was truly vaccine-caused or just coincidental timing with a viral infection.

---

## Ground Truth vs Pipeline
| | Ground Truth | Pipeline Result |
|---|-------------|----------------|
| **Group** | G2 (Confounded) | Conflicting factors detected |
| **Confounder** | Viral etiology | NCI=0.5 viral (SUSPECTED) |
| **Expected WHO** | B2 | **B2 ✅** |
| **Onset** | 5d | 5.0d |

---

*HexaVax-MAPS v3 | WHO AEFI Digital Manual | Total: 43.06s*
*Stage timing: S1=6.83s S2=0.0s S3=14.49s S4=0.0s S5=7.48s S6=14.26s*
